1. Home
  2. ALT vs SPIR Comparison

ALT vs SPIR Comparison

Compare ALT & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • SPIR
  • Stock Information
  • Founded
  • ALT 1997
  • SPIR 2012
  • Country
  • ALT United States
  • SPIR United States
  • Employees
  • ALT N/A
  • SPIR N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • SPIR Telecommunications Equipment
  • Sector
  • ALT Health Care
  • SPIR Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • SPIR Nasdaq
  • Market Cap
  • ALT 327.4M
  • SPIR 363.0M
  • IPO Year
  • ALT N/A
  • SPIR N/A
  • Fundamental
  • Price
  • ALT $3.59
  • SPIR $9.87
  • Analyst Decision
  • ALT Strong Buy
  • SPIR Strong Buy
  • Analyst Count
  • ALT 6
  • SPIR 4
  • Target Price
  • ALT $17.40
  • SPIR $16.75
  • AVG Volume (30 Days)
  • ALT 2.4M
  • SPIR 448.7K
  • Earning Date
  • ALT 11-11-2025
  • SPIR 08-13-2025
  • Dividend Yield
  • ALT N/A
  • SPIR N/A
  • EPS Growth
  • ALT N/A
  • SPIR N/A
  • EPS
  • ALT N/A
  • SPIR N/A
  • Revenue
  • ALT $20,000.00
  • SPIR $99,502,000.00
  • Revenue This Year
  • ALT N/A
  • SPIR N/A
  • Revenue Next Year
  • ALT $761,880.20
  • SPIR $6.19
  • P/E Ratio
  • ALT N/A
  • SPIR N/A
  • Revenue Growth
  • ALT N/A
  • SPIR N/A
  • 52 Week Low
  • ALT $2.90
  • SPIR $6.85
  • 52 Week High
  • ALT $11.16
  • SPIR $21.43
  • Technical
  • Relative Strength Index (RSI)
  • ALT 45.32
  • SPIR 55.66
  • Support Level
  • ALT $3.54
  • SPIR $9.50
  • Resistance Level
  • ALT $3.72
  • SPIR $10.07
  • Average True Range (ATR)
  • ALT 0.16
  • SPIR 0.40
  • MACD
  • ALT 0.02
  • SPIR 0.16
  • Stochastic Oscillator
  • ALT 21.87
  • SPIR 84.74

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About SPIR Spire Global Inc.

Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.

Share on Social Networks: